BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ma WW, Hidalgo M. Exploiting novel molecular targets in gastrointestinal cancers. World J Gastroenterol 2007; 13(44): 5845-5856 [PMID: 17990350 DOI: 10.3748/wjg.v13.i44.5845]
URL: https://www.wjgnet.com/1007-9327/full/v13/i44/5845.htm
Number Citing Articles
Melanie B. Thomas, Deborah Jaffe, Michael M. Choti, Jacques Belghiti, Steven Curley, Yuman Fong, Gregory Gores, Robert Kerlan, Phillipe Merle, Bert O'Neil, Ronnie Poon, Lawrence Schwartz, Joel Tepper, Francis Yao, Daniel Haller, Margaret Mooney, Alan Venook. Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning MeetingJournal of Clinical Oncology 2010; 28(25): 3994 doi: 10.1200/JCO.2010.28.7805
Dietmar W. Siemann. The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting AgentsCancer Treatment Reviews 2011; 37(1): 63 doi: 10.1016/j.ctrv.2010.05.001
Stephen Shuttleworth, Franck Silva, Cyrille Tomassi, Alexander Cecil, Thomas Hill, Helen Rogers, Paul Townsend. Progress in Medicinal Chemistry 2009; 48: 81 doi: 10.1016/S0079-6468(09)04803-6
Gerhard Treiber. mTOR inhibitors for hepatocellular cancer: a forward-moving targetExpert Review of Anticancer Therapy 2009; 9(2): 247 doi: 10.1586/14737140.9.2.247
Sylvestor A. Moses, M. Ahad Ali, Song Zuohe, Lei Du-Cuny, Li Li Zhou, Robert Lemos, Nathan Ihle, A. Geoffrey Skillman, Shuxing Zhang, Eugene A. Mash, Garth Powis, Emmanuelle J. Meuillet. In vitro and In vivo Activity of Novel Small-Molecule Inhibitors Targeting the Pleckstrin Homology Domain of Protein Kinase B/AKTCancer Research 2009; 69(12): 5073 doi: 10.1158/0008-5472.CAN-08-3839
Ayman O. Nasr, Mary F. Dillon, Susie Conlon, Paul Downey, Gang Chen, Adrian Ireland, Eamon Leen, David Bouchier-Hayes, Thomas N. Walsh. Acid suppression increases rates of Barrett’s esophagus and esophageal injury in the presence of duodenal refluxSurgery 2012; 151(3): 382 doi: 10.1016/j.surg.2011.08.021
Henryk Dudek, Darren H Wong, Rokhand Arvan, Anee Shah, Kathleen Wortham, Bo Ying, Rohan Diwanji, Wei Zhou, Benjamin Holmes, Hailin Yang, Wendy A Cyr, Yi Zhou, Aalok Shah, Ruchir Farkiwala, Michael Lee, Yiting Li, Garrett R Rettig, Michael A Collingwood, Sujit K Basu, Mark A Behlke, Bob D Brown. Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivoMolecular Therapy 2014; 22(1): 92 doi: 10.1038/mt.2013.233
Paul Hasty, Carolina B. Livi, Sherry G. Dodds, Diane Jones, Randy Strong, Martin Javors, Kathleen E. Fischer, Lauren Sloane, Kruthi Murthy, Gene Hubbard, Lishi Sun, Vincent Hurez, Tyler J. Curiel, Zelton Dave Sharp. eRapa Restores a Normal Life Span in a FAP Mouse ModelCancer Prevention Research 2014; 7(1): 169 doi: 10.1158/1940-6207.CAPR-13-0299
Wen Wee Ma, Joseph M. Herman, Antonio Jimeno, Daniel Laheru, Wells A. Messersmith, Christopher L. Wolfgang, John L. Cameron, Timothy M. Pawlik, Ross C. Donehower, Michelle A. Rudek, Manuel Hidalgo. A Tolerability and Pharmacokinetic Study of Adjuvant Erlotinib and Capecitabine with Concurrent Radiation in Resected Pancreatic CancerTranslational Oncology 2010; 3(6): 373 doi: 10.1593/tlo.10196
Michael A van Geer, Conny T Bakker, Naoya Koizumi, Hiroyuki Mizuguchi, John G Wesseling, Ronald PJ Oude Elferink, Piter J Bosma. Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction <italic>in vivo</italic>World Journal of Gastroenterology 2009; 15(22): 2754-2762 doi: 10.3748/wjg.15.2754
Chery Whipple, Murray Korc. Targeting angiogenesis in pancreatic cancer: rationale and pitfallsLangenbeck's Archives of Surgery 2008; 393(6): 901 doi: 10.1007/s00423-008-0280-z
Kathrin Rupertus, Christian Dahlem, Michael D. Menger, Martin K. Schilling, Otto Kollmar. Rapamycin Inhibits Hepatectomy-Induced Stimulation of Metastatic Tumor Growth by Reduction of Angiogenesis, Microvascular Blood Perfusion, and Tumor Cell ProliferationAnnals of Surgical Oncology 2009; 16(9): 2629 doi: 10.1245/s10434-009-0564-8